Water Street Appoints Jim Post as Executive Advisor
Chicago — Water Street announced today that it has expanded its team with the appointment of Jim Post as an executive advisor. Mr. Post will work with Water Street’s team of former health care executives and senior investment professionals to pursue growth opportunities in laboratory products and services.
Mr. Post has a strong record of leading teams and businesses to drive innovation in health care. As president of the anatomic pathology business for Thermo Fisher Scientific, Mr. Post spearheaded its turnaround and successful sale to global health care company PHC Holdings Corporation (PHC). He subsequently integrated the business into PHC as president and CEO of the newly formed entity, Epredia, where he helped position it as a global leader in precision cancer and tissue diagnostics. Prior to Thermo Fisher, Mr. Post held key management positions with Alere, the world leader in point-of-care and rapid diagnostic devices, including president of its global hospital business.
“During my 20+ years of leadership, I am most proud of building strong, mutually beneficial teams and relationships in health care. This is what attracted me to Water Street. It excels at forming partnerships that are focused on supporting founders and executives with achieving their goals for growth while making a positive impact in health care,” said Mr. Post.
Mr. Post began his career in the health care instrument business with United States Surgical, where he was promoted to positions of increasing responsibility, including vice president of sales. He is a graduate of the University of Rochester.